| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Medical Media Communications is a Des Plaines, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Amico Laboratories, Inc is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Marcus Daly Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Hamilton, MT. To find more information about Marcus Daly Memorial Hospital, please visit www.mdmh.org
Martin Memorial Health Systems is a Stuart, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.